Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Strategic Asset Allocation Index
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Strategic Asset Allocation Index of 21.7% as of September 2023. Strategic assets (PP&E of CN¥497.86 Million plus long-term investments of CN¥-) total CN¥497.86 Million, measured against net assets of CN¥2.29 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Jilin Jian Yisheng Pharmaceutical Co Ltd Strategic Asset Allocation Index (2008–2022)
This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of September 2023, the index stands at 21.7%, representing strategic assets of CN¥497.86 Million against net assets of CN¥2.29 Billion CNY. Explore how efficiently does Jilin Jian Yisheng Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Jilin Jian Yisheng Pharmaceutical Co Ltd (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jilin Jian Yisheng Pharmaceutical Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002566 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.4% | CN¥526.11 Million | CN¥526.11 Million | CN¥- | CN¥2.25 Billion | ▲ +0.6 pp |
| 2021 | 22.8% | CN¥501.49 Million | CN¥501.49 Million | CN¥- | CN¥2.20 Billion | ▲ +3.0 pp |
| 2020 | 19.9% | CN¥423.30 Million | CN¥423.30 Million | CN¥- | CN¥2.13 Billion | ▼ -1.1 pp |
| 2019 | 20.9% | CN¥430.53 Million | CN¥430.53 Million | CN¥- | CN¥2.06 Billion | ▼ -2.5 pp |
| 2018 | 23.4% | CN¥460.60 Million | CN¥460.60 Million | CN¥- | CN¥1.97 Billion | ▼ -0.7 pp |
| 2017 | 24.1% | CN¥458.12 Million | CN¥458.12 Million | CN¥- | CN¥1.90 Billion | ▼ -0.2 pp |
| 2016 | 24.3% | CN¥438.36 Million | CN¥438.36 Million | CN¥- | CN¥1.80 Billion | ▲ +1.5 pp |
| 2015 | 22.8% | CN¥398.36 Million | CN¥398.36 Million | CN¥- | CN¥1.75 Billion | ▲ +5.9 pp |
| 2014 | 16.9% | CN¥295.95 Million | CN¥295.95 Million | CN¥- | CN¥1.75 Billion | ▼ -0.7 pp |
| 2013 | 17.6% | CN¥295.08 Million | CN¥295.08 Million | CN¥- | CN¥1.68 Billion | ▲ +2.1 pp |
| 2012 | 15.5% | CN¥246.25 Million | CN¥246.25 Million | CN¥- | CN¥1.59 Billion | ▲ +0.9 pp |
| 2011 | 14.6% | CN¥221.51 Million | CN¥221.51 Million | CN¥- | CN¥1.51 Billion | ▼ -39.7 pp |
| 2010 | 54.3% | CN¥195.32 Million | CN¥195.32 Million | CN¥- | CN¥359.40 Million | ▼ -2.6 pp |
| 2009 | 57.0% | CN¥160.13 Million | CN¥160.13 Million | CN¥- | CN¥280.99 Million | ▲ +11.4 pp |
| 2008 | 45.6% | CN¥100.19 Million | CN¥100.19 Million | CN¥- | CN¥219.89 Million | — |